Dermatologic and Ophthalmologic Treatment of Erythema Multiforme Major: A Case Report.
erythema multiforme major
hsv-1
mycoplasma pneumonia
nsaids
ocular complications
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
accepted:
28
12
2021
entrez:
3
2
2022
pubmed:
4
2
2022
medline:
4
2
2022
Statut:
epublish
Résumé
Erythema multiforme major (EMM) is a rare type IV cytotoxic reaction targeting keratinocytes of the mucosal surfaces and the dermis. Dusky, targetoid lesions with central clearing are classically present, which may become blistered and rupture. The disease is usually self-limited and managed with supportive care and treatment of the underlying condition. The most common triggering factors are adverse reactions to medications, herpes simplex virus (HSV), and
Identifiants
pubmed: 35111489
doi: 10.7759/cureus.20854
pmc: PMC8795857
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e20854Informations de copyright
Copyright © 2021, Senger et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Cureus. 2018 Oct 16;10(10):e3459
pubmed: 30564538
Cornea. 2007 Feb;26(2):123-9
pubmed: 17251797
Ocul Surf. 2010 Oct;8(4):193-203
pubmed: 20964982
Int J Dermatol. 2012 Aug;51(8):889-902
pubmed: 22788803
J Can Dent Assoc. 2009 Oct;75(8):597-601
pubmed: 19840503
Am Fam Physician. 2019 Jul 15;100(2):82-88
pubmed: 31305041
Clin Rev Allergy Immunol. 2018 Feb;54(1):177-184
pubmed: 29352387
J Oral Pathol Med. 2010 Nov;39(10):747-52
pubmed: 20738747
Am Fam Physician. 2006 Dec 1;74(11):1883-8
pubmed: 17168345
Arch Dis Child. 2000 Oct;83(4):347-52
pubmed: 10999875